The Quadruple Screening, also known as "Quad Test", is a prenatal test given between the 16th and 21st weeks of pregnancy. It's primarily designed to gauge the risk of certain chromosomal disorders including Down Syndrome (trisomy 21), Edwards Syndrome (trisomy 18), and neural tube defects such as spina bifida. 

Our advanced prenatal care services offer a high level of accuracy and reliability. However, it's important to bear in mind that the Quad Test doesn't confirm a diagnosis. Instead, results provide a risk rate, indicating likelihood. If results show a higher risk, further diagnostic tests such as amniocentesis or chorionic villus sampling may be recommended.

The Quad Test measures four substances in a pregnant woman's blood: Alpha-fetoprotein (AFP), Human chorionic gonadotropin (hCG), Inhibin A and Estriol. AFP is a protein produced by the fetal liver, while the other three substances are produced by the placenta.

How the test is done:
A sample of blood will be taken from the mother's arm and sent to a lab for analysis. 

What to expect from the results:
It typically takes about a week to receive the results. However, be informed that a "positive" test result doesn't mean the baby has a birth defect, it only means the risk is higher and further testing may be needed. 

Our team of medical professionals and patient care coordinators are here to guide and support you throughout the process, answering any questions and catering to your needs surrounding the Quad Test. 

Please don't hesitate to get in touch if you require more information about our Quadruple Screening services, or if you wish to schedule an appointment.